Cargando…
SARS-CoV-2 infection in pediatric population
In December 2019, in Wuhan (Hubei, China), the first COVID-19 cases due to SARS-COV-2 had been reported. On July 1st 2020, more than 10.268.839 million people had developed the disease, with at least 506.064 deaths. At present, Italy is the third country considering the number of cases (n=240.760),...
Autores principales: | Manti, Sara, Licari, Amelia, Montagna, Lorenza, Votto, Martina, Leonardi, Salvatore, Brambilla, Ilaria, Castagnoli, Riccardo, Foiadelli, Thomas, Marseglia, Gian Luigi, Cardinale, Fabio, Caffarelli, Carlo, Tosca, Maria Angela, Cravidi, Claudio, Duse, Marzia, Chiappini, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023063/ https://www.ncbi.nlm.nih.gov/pubmed/33004773 http://dx.doi.org/10.23750/abm.v91i11-S.10298 |
Ejemplares similares
-
Food Allergies: Current and Future Treatments
por: Licari, Amelia, et al.
Publicado: (2019) -
Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5–11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
por: Novembre, Elio, et al.
Publicado: (2022) -
What is new in anaphylaxis?
por: Martelli, Alberto, et al.
Publicado: (2020) -
Allergy and COVID-19
por: De Filippo, Maria, et al.
Publicado: (2021) -
Tuberculosis and TNF-α inhibitors in children: how to manage a fine balance
por: Parigi, Sara, et al.
Publicado: (2020)